SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Tuesday reported a loss of $71.9 million in its fourth quarter.

On a per-share basis, the San Carlos, California-based company said it had a loss of 18 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.

The biotechnology company posted revenue of $86.7 million in the period.

For the year, the company reported a loss of $391 million, or $1.09 per share. Revenue was reported as $263.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA